# Nipent

NDC: 0409-0801
Generic name: PENTOSTATIN
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20070815

FDA application: NDA020122

## Active ingredients

- PENTOSTATIN: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-0801"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-0801
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=674e0e6d-46ed-4868-9196-04019d667716